Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
The Pharmacogenomics Journal
|
August 21, 2013
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan
A Sebio, D Páez, J Salazar, et al.
Revista De Neurologia
|
April 2, 1999
[Alterations in functional proteins. Calpaine-3 deficiency]
A López de Munain, A Urtasun, J J Poza, et al.
Haematologica
|
January 4, 1998
Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma
J F Nomdedéu, I Lete, M Baiget, et al.
Breast Cancer Research and Treatment
|
March 30, 2011
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry
B Graña, L Fachal, E Darder, et al.
Leukemia
|
November 11, 2005
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
G Perea, A Lasa, A Aventín, et al.
American Journal of Human Genetics
|
May 20, 1999
Calpainopathy-a survey of mutations and polymorphisms
I Richard, C Roudaut, A Saenz, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
The Pharmacogenomics Journal
|
August 21, 2013
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan
A Sebio, D Páez, J Salazar, et al.
Revista De Neurologia
|
April 2, 1999
[Alterations in functional proteins. Calpaine-3 deficiency]
A López de Munain, A Urtasun, J J Poza, et al.
Haematologica
|
January 4, 1998
Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma
J F Nomdedéu, I Lete, M Baiget, et al.
Breast Cancer Research and Treatment
|
March 30, 2011
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry
B Graña, L Fachal, E Darder, et al.
Leukemia
|
November 11, 2005
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
G Perea, A Lasa, A Aventín, et al.
American Journal of Human Genetics
|
May 20, 1999
Calpainopathy-a survey of mutations and polymorphisms
I Richard, C Roudaut, A Saenz, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
Page
of 5